Dipeptidyl Peptidase-4 Inhibitor Prevents the Progression of Heart Failure After Myocardial Infarction

被引：0
|
作者：
Kubota, Akihiko [1 ]
Takano, Hiroyuki [2 ]
Hasegawa, Hiroshi [1 ]
Kobara, Yuka [1 ]
Wang, Haixiu [2 ]
Nagamine, Akari [2 ]
Ono, Ayaka [2 ]
Kameda, Yoshihito [1 ]
Hirose, Masanori [1 ]
Tadokoro, Hiroyuki [3 ]
Kobayashi, Yoshio [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chiba, Japan
[3] Tokai Univ, Sch High Technol Human Welf, Dept Biomed Engn, Numazu, Japan
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Ischemic heart disease; Pharmacology; Heart failure;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11421
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dipeptidyl peptidase-4 inhibitor prevents the progression of heart failure after myocardial infarction in mice
    Kubota, A.
    Hasegawa, H.
    Kameda, Y.
    Kobara, Y.
    Hirose, M.
    Tadokoro, H.
    Komuro, I.
    Takano, H.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 616 - 616
  • [2] Cardioprotective Effects of Dipeptidyl Peptidase-4 Inhibitor on Diabetes Mice after Myocardial Infarction
    Kameda, Yoshihito
    Hasegawa, Hiroshi
    Kobara, Yuka
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Komuro, Issei
    Takano, Hiroyuki
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S179 - S180
  • [3] DIPEPTIDYL PEPTIDASE-4 INHIBITOR ATTENUATES CARDIAC DYSFUNCTION AND ADVERSE REMODELING AFTER MYOCARDIAL INFARCTION
    Chattipakorn, Nipon
    Inthachai, Tharnwimol
    Lekawanvijit, Suree
    Chattipakorn, Siriporn
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A905 - A905
  • [4] Heart failure and dipeptidyl peptidase-4 inhibitors
    Krum, Henry
    Skiba, Marina
    Wu, Shiying
    Hopper, Ingrid
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (06) : 603 - 607
  • [5] Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?
    Lee, Yong-ho
    DIABETES & METABOLISM JOURNAL, 2015, 39 (03) : 204 - 206
  • [6] Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
    Apaijai, Nattayaporn
    Inthachai, Tharnwimol
    Lekawanvijit, Suree
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    JOURNAL OF ENDOCRINOLOGY, 2016, 229 (03) : 245 - 258
  • [7] DIPEPTIDYL PEPTIDASE-4 INHIBITOR HAS BENEFICIAL EFFECTS ON POST-MYOCARDIAL INFARCTION HEART IN DIABETIC MICE
    Kubota, Akihiko
    Hasegawa, Hiroshi
    Kameda, Yoshihito
    Yuka, Kobara
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Komuro, Issei
    Takano, Hiroyuki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E596 - E596
  • [8] Incident heart failure and myocardial infarction in sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitor users
    Zhou, Jiandong
    Lee, Sharen
    Leung, Keith Sai Kit
    Wai, Abraham Ka Chung
    Liu, Tong
    Liu, Ying
    Chang, Dong
    Wong, Wing Tak
    Wong, Ian Chi Kei
    Cheung, Bernard Man Yung
    Zhang, Qingpeng
    Tse, Gary
    ESC HEART FAILURE, 2022, 9 (02): : 1388 - 1399
  • [9] Dipeptidyl peptidase-4 inhibitor approaches
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2017, 9 (01) : 5 - 7
  • [10] Dipeptidyl Peptidase-4 Inhibitors and Heart Failure Risk Analysis
    Vardarli, I.
    Ozcelik, C.
    KARDIOLOGE, 2014, 8 (06): : 448 - 450
12345